| Literature DB >> 26362511 |
Jane C Hurley1, Kevin E Hollingshead, Michael Todd, Catherine L Jarrett, Wesley J Tucker, Siddhartha S Angadi, Marc A Adams.
Abstract
BACKGROUND: Walking is a widely accepted and frequently targeted health promotion approach to increase physical activity (PA). Interventions to increase PA have produced only small improvements. Stronger and more potent behavioral intervention components are needed to increase time spent in PA, improve cardiometabolic risk markers, and optimize health.Entities:
Keywords: Fitbit; SMS; exercise; inactive; just in time adaptive interventions; mHealth; overweight; percentile schedule of reinforcement; text messaging
Year: 2015 PMID: 26362511 PMCID: PMC4704955 DOI: 10.2196/resprot.4856
Source DB: PubMed Journal: JMIR Res Protoc ISSN: 1929-0748
Inclusion and exclusion criteria for the WalkIT trial.
| Participants | Criteria | |
|
| ||
|
| Home residence | Live in Maricopa County, Arizona. |
|
| Age | Between 18-60 years. |
|
| Body Mass Index | Between 25-55 kg/m2. |
|
| Inactive | Not meeting or exceeding physical activity (PA) recommendations (ie, ≥10,000 steps/day on ≥5 days/week). |
|
| Health | No contraindicated condition(s) as assessed via Physical Activity Readiness Questionnaire (PARQ+). |
|
| Medication use | No medication(s) use that prohibits a moderate intensity physical activity program or testing. |
|
| Pregnancy status | Not currently pregnant or planning to become pregnant in the next 4 months. |
|
| Staying within study area | Not planning to leave for ≥10 days or live outside of Maricopa County in the next 4 months. |
|
| Concurrent program | Not currently in a physical activity, diet, or weight loss program (eg, Weight Watchers). |
|
| Computer access | Access to personal Windows or Mac machine on a daily basis. |
|
| Internet access | Access to email and the Internet daily. |
|
| Mobile phone access | Has mobile phone with text messaging; willing to send and receive up to 3-5 texts per day. |
|
| ||
|
| Vaso-active medications | No supplements or over-the-counter medications (eg, calcium, non-steroidal anti-inflammatories) at least 4 days prior to visits. |
|
| Female menstrual phase | Within 7 days of onset of menses or >12 months post-menopause at time of visits. |
Figure 1Illustration of 2x2 factorial design.
Figure 2Schematic for intensive adaptive intervention system.
Secondary outcome measures.
| Measure | Description | Frequency | |||
| Pre-post | Once | Other | |||
|
| |||||
|
| IPAQ long form | IPAQ long form; 31-item survey designed to capture details on domain-specific physical activity with acceptable test-retest ( | x |
|
|
|
| Neighborhood | Neighborhood Environment Walkability Scale abbreviated; 54-item survey to measure neighborhood characteristics [ |
| xb |
|
|
| Monetary choice | Delayed discounting protocol using 27-item self-administered questionnaire [ |
| xc |
|
|
| Satisfaction | Consumer satisfaction style questionnaire for rating experience and providing feedback; question number and type differed by intervention assignment. |
| xc |
|
|
| Self-Efficacy | Single-item Ecological Momentary Assessment (EMA) of self-efficacy (0-9 Likert-type scale) delivered via SMS on 21 random intervention days. Item language based on previous work [ |
|
| x |
|
| |||||
|
| Height and weight | Measured using digital stadiometer and scale (Seca 284 measuring station, Seca GmbH & co. KG). | x |
|
|
|
| Aerobic fitness | Aerobic capacity (VO2peak) estimated using a submaximal continuous treadmill ramp protocol (modified Balke) and the Foster equation [ | x |
|
|
|
| Body compositiona | Dual-energy x-ray absorptiometry (Lunar iDXA, GE Healthcare). | x |
|
|
|
| Blood pressurea | Brachial and central blood pressure assessed during pulse wave analysis using Sphymocor XCEL (AtCor Medical Inc) [ | x |
|
|
|
| Arterial stiffnessa | Carotid-femoral pulse wave velocity assessed using Sphymocor XCEL (AtCor Medical Inc) [ | x |
|
|
|
| Biochemicala | Venous blood samples for cardiovascular risk and inflammatory markers; post-centrifugation samples archived in aliquots at -80°C. | x |
|
|
aMeasured in the vascular subset of participants.
bMeasured once at initial visit; second done at follow-up only if moved during study.
cMeasured at follow-up visit only.